この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Jayendrakumar P.に依頼
India
M.Pharma, Ph.D.(Pr.), MBA, FSFRC, FIPES, IAOTP Honoured Member
プロフィール概要
専門分野
サービス
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting,
Newswriting
Research
User Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Systematic Literature Review
Consulting
Regulatory Consulting
Data & AI
Statistical Analysis,
Data Processing,
Data Insights
Product Development
Formulation,
Stability/Shelf Life Testing,
Material Sourcing,
Product Validation,
Manufacturing,
Concept Development
職務経験
Ganpat University
1月 2020 - 現在 ![]()
Technical Lead
Natoli Engineering Company, USA
10月 2019 - 現在 ![]()
Director & Chief Executive Officer
Pyrrhic Pharma Private Limited
10月 2019 - 現在 ![]()
Research Scientist
Xylopia Lab Private Limited
7月 2019 - 9月 2019 ![]()
Deputy Manager
Zydus Cadila
8月 2014 - 6月 2019 ![]()
Research Scientist
Alkem Laboratories Ltd
3月 2014 - 8月 2014 ![]()
Research Assistant
Sun Pharma Advanced Research (India)
7月 2011 - 3月 2014 ![]()
学歴
Ph.D. (Pharmaceutical Science)
Ganpat University
- 現在 ![]()
Master in Industrial Pharmacy (M. Pharma)
Ganpat University
2009 - 2011 ![]()
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel, Ronak Patel, Payalben Patel (2021). Carbon Nanotube (CNTs): Structure, Synthesis, Purification, Functionalisation, Pharmacology, Toxicology, Biodegradation and Application as Nanomedicine and Biosensor . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). Role of Secondary Attack Rate in The Surge of COVID 19 Cases: A Comparative Retrospective Cohort Study between First Wave and Second Wave of COVID 19 . The Journal of Pharmaceutical Sciences and Medicinal Research.
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). A Comprehensive Overview On The Most Recent Trends In Covid-19 Diagnosis, Treatment Options And Vaccine Development Status . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Shalin Parikh, Ronak Patel, Shwetaben Patel(2021). Art Of Designing A Novel Drug Formulation With Patient In Mind . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel(2021). Fabrication And In-Vitro Analysis Of Mouth Dissolving Tablets Of Ondansetron Using Water Insoluble Super Disintegrant . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
Jayendrakumar Patel, Mamta Nasit, Meshva Patel, Ajay Solanki(2021). Solid-State Lipid - Based Lipid Drug Delivery System . The Journal of Pharmaceutical Sciences and Medicinal Research. 001. (01). The Journal of Pharmaceutical Sciences and Medicinal Research
(2012). Single Core Osmotic Pump (SCOP): Development of Single Layer Osmotic controlled release tablet for poorly soluble drug . Journal of Pharmaceutical Technology and Drug Research.
OTHER
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel(2021). Unrestricted Social Interaction: Underappreciated Cause of COVID 19 Surge . Research Square Platform {LLC}
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .
Jayendrakumar Patel, Shalin Parikh, Rakesh Patel, Shwetaben Patel, Ronak Patel, Payalben Patel, Ankita Patel (2021). COVID-19 Potential To Infect 4.44% Indian Population .
CONFERENCE POSTER
(2011). Formulation and Development of Single layer osmotic controlled release tablet of Sertraline Hydrochloride.
PATENT
A Novel Oral Gastroretentive Pharmaceutical Dosage Form.
A Novel Pulsatile Drug Delivery System.
Abuse Deterrent Pharmaceutical Composition: Therapeutically Effective For A Patient And Deterrent To An Abuser.
Extended Release Osmotic Dosage Forms Comprising High Methylphenidate Hydrochloride Load.
Pharmaceutical Abuse Deterrent Composition Constructed in More Than One Strength.
Pharmaceutical Abuse Deterrent Dosage Form.
Tamper Resistant Pharmaceutical Composition.